Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2007

View Archived Issues

Summit and Evolva to codevelop new drugs for infectious diseases

Update on Protalex's phase I trial of PRTX-100

Positive results for AVI-5126 cardiovascular restenosis preventer

BioLineRx begins phase II trial of BL-1020 for schizophrenia

GSK declines option to develop Exelixis compound XL-647 licensed to SEI

Osiris and Genzyme to codevelop Prochymal for ARS

Siga and USAMRIID identify small-molecule inhibitors of Filoviridae viral entry

Abbott discloses novel antiviral agents in recent patent

Pyrazoline-based SARM with strong anabolic and partial androgenic/antiandrogenic effects in rats

Intranasal immunization with VLP vaccine protects against pandemic flu virus

Trypanosoma vaccine candidates comprised of tubulin peptides and mosaic virus

Genzyme reports second quarter 2007 results

CSL Behring announces FDA approval of Privigen

Omrix submits appplication to the EMEA for marketing approval of Evicel

Lybrel, first low-dose combination oral contraceptive now available in the U.S.

Safety and tolerability of HPV16 E6E7 vaccine reported in HIV-positive, HPV-infected patients

Significant antiviral activity with etravirine in HIV-positive, NNRTI-resistant patients

Fully human MAbs effective against highly pathogenic avian influenza virus

Positive results for Intellect's single-dose phase Ia trial of Oxigon

OSI transfers all rights to E-10030 and PDGF program to Ophthotech

ImClone and Bristol-Myers expand Erbitux codevelopment agreement

Positive preclinical results for Gene Logic's GL-1001 for IBD

Abbott begins phase I study of ABT-560 for CNS disorders

Epix presents new 5-HT6 receptor antagonist with beneficial effects in animal model of schizophrenia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...